40mg Regonat Regorafenib Tablets

40mg Regonat Regorafenib Tablets Specification

Origin of Medicine
India

Dosage Form
Oral

Indication
Gastrointestinal stromal tumor (GIST), metastatic colorectal cancer, hepatocellular carcinoma

Brand Name
Regonat

Life Span
24 months from date of manufacture

Salt Composition
Regorafenib 40 mg

Pacakaging (Quantity Per Box)
28 tablets

Packaging Type
Box

Drug Type
Allopathic

Ingredients
Regorafenib

Physical Form
Tablets

Function
Anticancer, tyrosine kinase inhibitor

Recommended For
Adults with advanced gastrointestinal stromal tumors, metastatic colorectal cancer, and hepatocellular carcinoma

Dosage
As prescribed by the physician, typically 160 mg (four 40 mg tablets) once daily for 21 days of a 28-day cycle

Dosage Guidelines
Follow physician guidelines closely, swallow tablets whole with water after a light meal

Suitable For
Adults

Quantity
28 tablets per box

Storage Instructions
Store below 30C, protect from moisture and light

Shape
Oval, film-coated tablet

Contraindications
Hypersensitivity to regorafenib or any excipients

Therapeutic Category
Oncology

Prescription Required
Yes

Registration Status
Approved for oncology indications

Side Effects
Fatigue, hand-foot syndrome, hypertension, diarrhea, hepatotoxicity

Administration Route
Oral

Manufactured By
Natco Pharma Limited

Marketed In
Global (specifically available in India and export markets)

International Brand Equivalence
Stivarga

Color
Light pink

About 40mg Regonat Regorafenib Tablets

Packaging Size	3 x 28 Tablets
Form	Tablet
Strength	40mg
Manufacturer	Natco
Packaging Type	Box
Brand	Regonat
Treatment	Treatment Of Cancers

Regonat Tablet is used in the treatment of cancers of colon and rectum. Diarrhea may occur as a side effect. Use a reliable contraceptive

Key Therapeutic Benefits

Regonat 40mg is primarily prescribed for adults with advanced gastrointestinal stromal tumors, metastatic colorectal cancer, and hepatocellular carcinoma. The medication inhibits cancer cell growth through targeted blocking of multiple enzymes involved in tumor progression. When taken as prescribed, Regonat may help slow disease progression and improve treatment outcomes in these challenging conditions.

How to Take Regonat 40mg Tablets

Regonat is taken orally, typically in a dose of 160mg (four 40mg tablets) once daily, for 21 consecutive days followed by seven days off, as part of a 28-day cycle. The tablets should be swallowed whole with water after a light meal. It's crucial to follow your physician's instructions closely and never change your dosage or schedule without consulting a healthcare provider.

Safety, Storage, and Handling Instructions

Store Regonat tablets in their original packaging, below 30C, protected from moisture and light. Keep out of reach of children and avoid use if you have a known hypersensitivity to regorafenib or any of the excipients. Always handle the medication with clean, dry hands to preserve its efficacy throughout its 24-month shelf life.

FAQ's of 40mg Regonat Regorafenib Tablets:

Q: What conditions is Regonat 40mg prescribed for?

A: Regonat 40mg is indicated for adults with advanced gastrointestinal stromal tumors (GIST), metastatic colorectal cancer, and hepatocellular carcinoma. It is used when prior standard therapies have failed or are unsuitable.

Q: How should I take Regonat tablets for best effectiveness?

A: Take Regonat exactly as prescribed, typically 160mg once daily for 21 days in a 28-day cycle. Swallow the tablets whole with water after a light meal and do not crush, break, or chew them.

Q: What are the main side effects of Regonat?

A: Common side effects of Regonat may include fatigue, hand-foot syndrome, diarrhea, hypertension, and liver toxicity. Contact your healthcare provider if you experience any severe or unusual symptoms.

Q: Where is Regonat available and is a prescription required?

A: Regonat is widely marketed in India and exported to various countries. It is a prescription-only medication, meaning you must consult a qualified physician to obtain it.

Q: Who should not take Regonat 40mg?

A: You should avoid Regonat if you have known hypersensitivity to regorafenib or any of the tablet's excipients. Always inform your doctor of any allergies before starting treatment.

Q: What are the storage requirements for Regonat tablets?

A: Store the tablets in their original box, below 30C, and protect them from moisture and light. Ensure the medication is kept out of reach of children and only used within its shelf life.

Q: What are the potential benefits of using Regonat in cancer treatment?

A: Regonat acts as a targeted therapy that can help slow the progression of certain advanced cancers and may improve overall treatment outcomes, especially when standard therapies are ineffective.

Get Latest Price